News Releases | American College of Emergency Physicians

Site Body

Main Content

ACEP Applauds House Passage of Synthetic Drug Control Act
Sep 29, 2016

WASHINGTON — In response to the passage of H.R. 3537 “Dangerous Synthetic Drug Control Act of 2015,” the president of the American College of Emergency Physicians Jay Kaplan, MD, FACEP, released a statement:

“I commend the House of Representatives on the bipartisan passage (258-101) of the ‘Dangerous Synthetic Drug Control Act.’ In every community across this nation, my colleagues and I are treating more and more patients who have experienced synthetic drug toxicity or poisoning.  The use of these dangerous chemicals has directly led to violence, hospitalizations and deaths.  The public should not be fooled about synthetic drugs.  Even though these products may be hiding in plain sight, they are colorfully-packaged poisons.

“However, there is still much work to be done to end this terrible problem.  We applaud the House for adding these dangerous, illicit substances to Schedule I of the “Controlled Substances Act,” and we look forward to working with our Congressional champions to continue this fight for our patients.

“I especially want to thank Rep. Charlie Dent (R-PA) and Rep. Jim Himes (D-CT) for their sponsorship of this bill as well as former ACEP president, Alex Rosenau, DO, FACEP for his effort to make this law.”

The bill is now headed to the United States Senate. 

ACEP is the national medical specialty society representing emergency medicine. ACEP is committed to advancing emergency care through continuing education, research and public education. Headquartered in Dallas, Texas, ACEP has 53 chapters representing each state, as well as Puerto Rico and the District of Columbia. A Government Services Chapter represents emergency physicians employed by military branches and other government agencies. 

# # #

For further information: Mike Baldyga | 202-370-9288 |